What is Syntegra?
Syntegra operates at the intersection of machine learning and healthcare, addressing the critical bottleneck of data accessibility in medical research. By transforming electronic medical records into high-fidelity synthetic datasets, the company enables researchers to derive meaningful insights without exposing personal health information. This approach effectively mitigates the legal and ethical risks associated with traditional data sharing, providing a robust solution for health systems, insurance providers, and clinical research organizations. As a leader in the synthetic data space, Syntegra is redefining how the industry approaches data-driven innovation while maintaining the highest standards of patient confidentiality.
How much funding has Syntegra raised?
Syntegra has raised a total of $5.6M across 1 funding round:
Angel/Seed
$5.6M
Angel/Seed (2022): $5.6M with participation from villageglobal.com, Hike Ventures, Wisconn Valley Ventures, First Spark Ventures, Vastly Valuable Ventures, Sweat Equity Ventures, GRIDS Capital, Berkeley Catalyst Fund, Innovation Global Capital, Impact Venture Capital, and Launchpad Capital
Key Investors in Syntegra
Innovation Global Capital
Innovation Global Capital builds disruptive early-stage companies that transform industries through technology and innovation, with a specific focus on AI and digital healthcare.
First Spark Ventures
First Spark Ventures is a Deep Tech venture capital fund that invests in breakthrough technologies aimed at enhancing health, safety, and productivity, particularly in digital biology.
Hike Ventures
Hike Ventures is an AI-focused venture capital fund that specializes in seed-stage startups, leveraging deep expertise in algorithmic business models.
What's next for Syntegra?
With this major enterprise-level funding, Syntegra is poised to accelerate its product development roadmap and expand its footprint across global healthcare markets. The strategic focus will likely center on enhancing the realism and utility of its synthetic models to support increasingly complex clinical trials and predictive analytics. By leveraging its recent capital infusion, the company aims to solidify its position as the standard-bearer for privacy-preserving data infrastructure, ultimately facilitating a new era of collaborative research that is both secure and highly scalable.
See full Syntegra company page
